BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33620125)

  • 1. The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Stepan KO; Mazul AL; Skillington SA; Paniello RC; Rich JT; Zevallos JP; Jackson RS; Pipkorn P; Massa S; Puram SV
    Head Neck; 2021 Jun; 43(6):1797-1811. PubMed ID: 33620125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Analysis of Treatment Management and Survival Outcomes in Nasopharyngeal Carcinoma.
    Goshtasbi K; Lehrich BM; Birkenbeuel JL; Abiri A; Harris JP; Kuan EC
    Otolaryngol Head Neck Surg; 2021 Jul; 165(1):93-103. PubMed ID: 33231508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph Node Status and Outcomes for Nasopharyngeal Carcinoma According to Histological Subtypes: A SEER Population-Based Retrospective Analysis.
    Guo R; Wu H; Wang J; Lian CL; He ZY; Zhang WW; Chen YX; Wu SG
    Adv Ther; 2019 Nov; 36(11):3123-3133. PubMed ID: 31559602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subtype Specific Nasopharyngeal Carcinoma Incidence and Survival Trends: Differences between Endemic and Non-Endemic Populations.
    Argirion I; Zarins KR; Suwanrungruang K; Pongnikorn D; Chitapanarux I; Sriplung H; Vatanasapt P; Rozek LS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3291-3299. PubMed ID: 33247687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Mortality Due to Nasopharyngeal Carcinoma and Race in the United States From 2007 to 2016.
    Raslan S; Rodriguez E; Zheng C; Lozano J; Barengo NC; Sargi Z
    Asian Pac J Cancer Prev; 2023 Mar; 24(3):915-921. PubMed ID: 36974545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological subtype remains a prognostic factor for survival in nasopharyngeal carcinoma patients.
    Pan XX; Liu YJ; Yang W; Chen YF; Tang WB; Li CR
    Laryngoscope; 2020 Mar; 130(3):E83-E88. PubMed ID: 31188486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma.
    Ooft ML; van Ipenburg J; Braunius WW; Stegeman I; Wegner I; de Bree R; Overbeek LI; Koljenović S; Willems SM
    Oral Oncol; 2016 May; 56():40-6. PubMed ID: 27086485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factor analysis in patients with early-stage nasopharyngeal carcinoma in the USA.
    Liu P; Xue XM; Zhang C; Zhou HW; Ding ZW; Jiang YK; Wang L; Shen WD; Yang SM; Wang FY
    Future Oncol; 2023 May; 19(15):1063-1072. PubMed ID: 37283023
    [No Abstract]   [Full Text] [Related]  

  • 9. Survival effect of pretreatment FDG-PET-CT on nasopharyngeal cancer.
    Yang PC; Chen WM; Chen M; Shia BC; Wu SY; Chiang CW
    J Formos Med Assoc; 2023 Jan; 122(1):36-46. PubMed ID: 35999158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
    Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
    Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
    Duan YY; Deng J; Su DF; Li WQ; Han Y; Li ZX; Huan XZ; Zhu SH; Yang QL; Hu W; Xin MZ; Tang LQ; Mai HQ; Fan YY; He Y
    Support Care Cancer; 2021 Sep; 29(9):5371-5381. PubMed ID: 33686519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD3+T-lymphocyte infiltration is an independent prognostic factor for advanced nasopharyngeal carcinoma.
    Al-Rajhi N; Soudy H; Ahmed SA; Elhassan T; Mohammed SF; Khoja HA; Ghebeh H
    BMC Cancer; 2020 Mar; 20(1):240. PubMed ID: 32199452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
    Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
    Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of prognostic nomograms in patients with ascending type of nasopharyngeal carcinoma: Retrospective study based on SEER database.
    Chen KH; Jiang YT; Zhao R; Sun YC; Zhu XD
    Head Neck; 2022 Dec; 44(12):2649-2659. PubMed ID: 36054033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors of nasopharyngeal carcinoma patients in a tertiary referral hospital: a retrospective cohort study.
    Siti-Azrin AH; Norsa'adah B; Naing NN
    BMC Res Notes; 2017 Dec; 10(1):705. PubMed ID: 29212521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of prognostic nutritional index in nasopharyngeal carcinoma: A meta-analysis containing 4511 patients.
    Tu X; Ren J; Zhao Y
    Oral Oncol; 2020 Nov; 110():104991. PubMed ID: 32919361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Mortality in Pediatric vs Adult Nasopharyngeal Carcinoma.
    Richards MK; Dahl JP; Gow K; Goldin AB; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Hawkins DS; Parikh SR
    JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):217-22. PubMed ID: 26769566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinoma.
    Qamar S; King AD; Ai QH; Mo FKF; Chen W; Poon DMC; Tong M; Ma BB; Yeung DK; Wang YX; Yuan J
    Eur Radiol; 2020 Nov; 30(11):6339-6347. PubMed ID: 32588210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
    Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
    Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between time from diagnosis to treatment and survival of patients with nasopharyngeal carcinoma: A population-based cohort study.
    Wei X; Yu S; Wang J; Xiang Z; Liu L; Min Y
    Curr Probl Cancer; 2024 Feb; 48():101060. PubMed ID: 38211418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.